3 Min Read
MOSCOW (Reuters) - Russian pharmaceutical firm Pharmasyntez said on Monday it was ready to ship up to 1 million packs of the remdesivir antiviral drug to India by end-May to help fight a surge in COVID-19 cases there, once it has received the approval of Russia’s government.
FILE PHOTO: An ampule of Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues. Ulrich Perrey/Pool via REUTERS
The move comes soon after the drug’s patent holder, U.S. firm Gilead Sciences, filed a lawsuit challenging the Russian government’s decision last year to let Pharmasynthez develop a generic version of remdesivir - which is called Remdeform - without their consent.
Cambodia s COVID-19 case tally exceeds 10,000 with 580 new cases
southeastasiapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from southeastasiapost.com Daily Mail and Mail on Sunday newspapers.
S Korean president calls for int l solidarity to overcome COVID-19 pandemic - World News
sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.